<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Benzocaine - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Benzocaine</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../../index.html">Home</a>
        <a class="btn small" href="../../index.html#/sickbay-meds">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Derm / ENT / Eye / Topicals</div>
      <h1>Benzocaine</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Benzocaine 10% Gel 5.3gm</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Oral mucosal pain (minor mouth/gum irritation, toothache, denture discomfort)</strong>
            <ul>
              <li>Apply small amount of 10% gel to affected area up to 4 times daily as needed</li>
              <li>Use sparingly; do not exceed recommended frequency</li>
            </ul>
          </li>
          <li><strong>Temporary relief only</strong>
            <ul>
              <li>Not a substitute for dental/medical evaluation of underlying problem</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Temporary relief of pain associated with minor oral irritation (toothache, canker sores, minor gum injury, denture irritation)</li>
          <li>Topical anesthetic for oral mucosa before minor procedures (when appropriate)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to benzocaine or other ester-type local anesthetics (PABA derivatives)</li>
          <li><strong>Methemoglobinemia risk:</strong> rare but serious; higher risk with excessive use, spray formulations, infants/children, G6PD deficiency, or methemoglobin reductase deficiency</li>
          <li>Avoid in infants under 2 years (teething gels): FDA warning due to methemoglobinemia risk</li>
          <li>Do not use on large areas or broken/inflamed tissue</li>
          <li>Avoid prolonged or frequent use</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Local: burning, stinging, contact dermatitis/allergic reaction</li>
          <li>Methemoglobinemia (rare but serious): cyanosis, dyspnea, altered mental status, tachycardia</li>
          <li>Hypersensitivity reactions (rash, angioedema)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>Apply small amount to affected area with clean finger or cotton swab</li>
          <li>Do not swallow immediately; allow to remain in contact with affected area</li>
          <li>Avoid eating/drinking for at least 1 hour after application if possible to maximize contact time</li>
          <li>Wash hands before and after application</li>
          <li>Do not use more than 4 times daily</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Symptom relief and duration of need</li>
          <li>Signs of methemoglobinemia (cyanosis, dyspnea, altered consciousness) if used repeatedly or excessively</li>
          <li>Local allergic reactions (rash, swelling)</li>
          <li>If pain persists &gt;7 days or worsens: reassess for underlying pathology requiring definitive care</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Provides temporary symptomatic relief only; identify and address underlying cause (dental abscess, trauma, etc.)</li>
          <li>If dental pain is severe or associated with fever/swelling: consider antibiotics and evacuation planning</li>
          <li>Document use and counsel on limitation: this is not treatment, only symptom control</li>
          <li>If methemoglobinemia suspected (rare): stop use immediately and arrange urgent medical evaluation/evacuation</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li>FDA Drug Safety Communication - Benzocaine and Methemoglobinemia: <a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-reports-rare-serious-and-potentially-fatal-adverse-effect-over" target="_blank" rel="noopener">https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-reports-rare-serious-and-potentially-fatal-adverse-effect-over</a></li>
          <li>Health Canada product monograph (benzocaine gel - Orajel): <a href="https://pdf.hres.ca/dpd_pm/00055394.PDF" target="_blank" rel="noopener">https://pdf.hres.ca/dpd_pm/00055394.PDF</a></li>
          <li>Medscape - Benzocaine Topical: <a href="https://reference.medscape.com/drug/benzocaine-topical-343409" target="_blank" rel="noopener">https://reference.medscape.com/drug/benzocaine-topical-343409</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
